dehydroepiandrosterone has been researched along with Hodgkin Disease in 3 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Outpatient adherence to oral medication regimens was evaluated in 50 adolescents and young adults with cancer: 21 patients with acute lymphoblastic leukemia or Hodgkin disease who were to take prednisone as a component of their chemotherapy regimen, and 29 patients with Hodgkin disease whose chemotherapy had been discontinued and who were to take penicillin for postsplenectomy prophylaxis." | 3.68 | Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. ( Chasalow, F; Festa, RS; Lanzkowsky, P; Tamaroff, MH, 1992) |
| "Hypothyroidism was significantly more common in patients after chemoradiotherapy than in those who received only chemotherapy (χ2=9." | 1.91 | [Endocrine disorders after combined chemoradiotherapy in Hodgkin Lymphoma survivors]. ( Fazullina, ON; Klimontov, VV; Pospelova, TI; Shebunyaeva, YY; Voytko, MS, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Voytko, MS | 1 |
| Klimontov, VV | 1 |
| Pospelova, TI | 1 |
| Shebunyaeva, YY | 1 |
| Fazullina, ON | 1 |
| Festa, RS | 1 |
| Tamaroff, MH | 1 |
| Chasalow, F | 1 |
| Lanzkowsky, P | 1 |
| Riessbeck, KH | 1 |
3 other studies available for dehydroepiandrosterone and Hodgkin Disease
| Article | Year |
|---|---|
[Endocrine disorders after combined chemoradiotherapy in Hodgkin Lymphoma survivors].
Topics: Adult; Chemoradiotherapy; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Hodgkin Dise | 2023 |
Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Biological Assay; Dehydroepiandrosterone; | 1992 |
[On a functional examination of the adrenal cortex for the purpose of radiotherapy].
Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Bone Neopl | 1967 |